Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP8237.RA3hCUSgkavx4ZVESnqahJcoObLkKGV0yVuR7OLhXE_9M130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8237.RA3hCUSgkavx4ZVESnqahJcoObLkKGV0yVuR7OLhXE_9M130_provenance.
• NP8244.RA5sIoBifN2WIw8W4P7VTvBbTrVrJAzOkuUs4ZECDoSKQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8244.RA5sIoBifN2WIw8W4P7VTvBbTrVrJAzOkuUs4ZECDoSKQ130_provenance.
• NP487796.RAlz1obOJJB1LnvnchSIXbGp74DfwFTS6d2Djs0f4Appc130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487796.RAlz1obOJJB1LnvnchSIXbGp74DfwFTS6d2Djs0f4Appc130_provenance.
• NP648079.RAcUdLddp7J_f62d0nZ1asb1oiYAFjq0AEiatQ8ZnXIbM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648079.RAcUdLddp7J_f62d0nZ1asb1oiYAFjq0AEiatQ8ZnXIbM130_provenance.
• assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP232112.RATnkibQ8kFMVRrOBr-J3hSZzBecHoJogsYJmzUIKNObM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232112.RATnkibQ8kFMVRrOBr-J3hSZzBecHoJogsYJmzUIKNObM130_provenance.
• NP6463.RA6RpufEmHWuQW0R9JixCIx1AwRxXzDUtOJtQ8w0VkHb8130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP6463.RA6RpufEmHWuQW0R9JixCIx1AwRxXzDUtOJtQ8w0VkHb8130_provenance.
• NP521926.RAErQ_FJ9mfZmPCNha3vtwHN-XMa1aHz92GO7hssc6oBk130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521926.RAErQ_FJ9mfZmPCNha3vtwHN-XMa1aHz92GO7hssc6oBk130_provenance.
• NP139733.RAu1YDlwJF0WmvC_j9AhkL0tgvgnFiZ2wm_PanZQKTLp4130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139733.RAu1YDlwJF0WmvC_j9AhkL0tgvgnFiZ2wm_PanZQKTLp4130_provenance.
• NP849668.RAdH5TuBxtPS600S6zK3taIgwH0UvCWzII76_Iy-YE5xs130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849668.RAdH5TuBxtPS600S6zK3taIgwH0UvCWzII76_Iy-YE5xs130_provenance.
• NP232231.RArgse6hXaxNak1BcapLHSq-oi-Q8PSWweVOl4y0ck8W8130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232231.RArgse6hXaxNak1BcapLHSq-oi-Q8PSWweVOl4y0ck8W8130_provenance.
• NP849667.RAus4K0Mv77yXINtzwehpT5b14Lex8kCxIWuEVubozuB0130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849667.RAus4K0Mv77yXINtzwehpT5b14Lex8kCxIWuEVubozuB0130_provenance.
• NP849669.RAsk8SfWXN1WyNl7s4A_lAGYm2K3ShL3npI0ryTH3blFA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849669.RAsk8SfWXN1WyNl7s4A_lAGYm2K3ShL3npI0ryTH3blFA130_provenance.
• NP140967.RAxFguXtNMBkmOutXOXB32F7sWAjDzpLzy9L9RIYCe1-E130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140967.RAxFguXtNMBkmOutXOXB32F7sWAjDzpLzy9L9RIYCe1-E130_provenance.
• NP232500.RA-7D08Ytt8T_lYOzPxhiymHGN_0Rdg6DfUtbTG8bAiKA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232500.RA-7D08Ytt8T_lYOzPxhiymHGN_0Rdg6DfUtbTG8bAiKA130_provenance.
• NP187887.RAIQ67HddNECduPHbwFQnzktB4piP-gW0bJfpi3jpTZvw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187887.RAIQ67HddNECduPHbwFQnzktB4piP-gW0bJfpi3jpTZvw130_provenance.
• NP187892.RAOZ-C3Wjyajw8kbjffYHSNhz0WR2Q9xcOEvVgjmuK4q0130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187892.RAOZ-C3Wjyajw8kbjffYHSNhz0WR2Q9xcOEvVgjmuK4q0130_provenance.